Tsuyoshi Hamaguchi

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

Yasuhiro Matsumura, Tsuyoshi Hamaguchi, Takashi Ura et al. · British Journal of Cancer · 2004 · 614 citations · Full text

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

Tsuyoshi Hamaguchi, Yasuhiro Matsumura, Masanobu Suzuki et al. · British Journal of Cancer · 2005 · 552 citations · Full text

Quantifying prion disease penetrance using large population control cohorts

Eric Vallabh Minikel, Sonia M. Vallabh, Monkol Lek et al. · Science Translational Medicine · 2016 · 448 citations · Full text

Phenolic Compounds Prevent Alzheimer’s Pathology through Different Effects on the Amyloid-β Aggregation Pathway

Tsuyoshi Hamaguchi, Kenjiro Ono, Atsushi Murase et al. · American Journal Of Pathology · 2009 · 393 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Amyloid-β Aggregation Pathway +11

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

Tsuyoshi Hamaguchi, Ken Kato, Hisateru Yasui et al. · British Journal of Cancer · 2007 · 286 citations · Full text